Overview:

The coronavirus pandemic has significantly impacted the educational and promotional efforts of life sciences companies, including limiting sales representative access to health care professionals and disrupting in-person events. As life sciences companies consider the new normal for the industry, various methods to actively engage health care providers, payers, and other customers are being considered in this era of social distancing. This requires compliance and legal professionals to analyze the risk profile and compliance parameters necessary to conduct these new activities while maintaining “safe distance” as prescribed by WHO and other bodies all over the world.